Cargando…
Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke
Levels of angiotensin converting enzyme 2 (ACE2), a cardio and neuro-protective carboxypeptidase, are dynamically altered after stroke in preclinical models. We sought to characterize the previously unexplored changes in serum ACE2 activity of stroke patients and the mechanism of these changes. Seru...
Autores principales: | Bennion, Douglas M, Rosado, Christian A, Haltigan, Emily A, Regenhardt, Robert W, Sumners, Colin, Waters, Michael F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843889/ https://www.ncbi.nlm.nih.gov/pubmed/27488276 http://dx.doi.org/10.1177/1470320316661060 |
Ejemplares similares
-
Angiotensin converting enzyme polymorphism and ischemic stroke
por: Salem, Gelan M., et al.
Publicado: (2020) -
Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
por: Brooks, John M., et al.
Publicado: (2018) -
Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke
por: Stankovic, Sanja, et al.
Publicado: (2011) -
Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014) -
Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)